1. Most Discussed
  2. Gainers & Losers
BCT 4.2¢

Potential for news before half year report in FEB

  1. Fargo

    121 Posts.

    On the 10 Nov Bluchiip released the announcement RE Bluechiip signs international agreement for technology integration
    In this announcement it mentions the following:
    "SIAD Group (SIAD) ITALY and Bluechiip have entered into a test and evaluation project for SIAD to integrate the Bluechiip cryotag into SIAD’s cryobags which are used to store cord blood and other biological products. On the successful completion of this test and evaluation after 3 months, both companies will negotiate the commercialisation of the integrated product."

    Well if my maths serves me correctly we are coming up to the end of that three month period.

    Perhaps this may be raised and further details provided in the half yearly report due around 28 Feb or even better beforehand.

    1. Glory Biotech Corp the org. in Korea who signed an agreement late OCT last year have had some time to bed down processes. Perhaps early days yet...
    2. Distribution Agreement with LBD Life Sciences in China Feb 2014 followed by Bluechiip system installed at the Shanghai Outdo Biotech Co., Ltd, a leading biobank in China sometime around July 2014. You would expect that some real development has occurred since that time.
    3. Distribution Agreement with Biospensa Resources Malaysia was signed way back in Feb 2014. Seems fair that things would have progressed.
    4. Genomics and Clinical Laboratory, North Carolina, USA, Australian Synchrotron, Australia and Southern Health, Victoria, Australia all made sales in April 2014. Further progress should be of interest.

    The distribution agreement for Korea had 330k minimum ordering obligations, the other agreements didn't detail min obligations but expect there would have been some agreement for this; unless of course Bluechiip management got wiser at the negotiating table ;)

    In the H/Yearly report we should see how much R&D tax concession was received; that would help cash flow.

    So there should be plenty of potential for news about progress and how the commercialisation strategy is panning out.
    At least in the next few weeks some questions will be answered.


Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.